COVID-19 Impact on Sysmex Corps Revenue and Operations (Medical Devices)

COVID-19 Impact on Sysmex Corps Revenue and Operations (Medical Devices)



Sysmex Corporation (Sysmex), is a leading diagnostics solutions company that offers hematology, urinalysis, information systems, and flow cytometry testing technology, headquartered in Japan with global manufacturing and sales reach. Sysmex’s product range include diagnostic solutions for hematology, urinalysis, and hemostasis as well as tools to efficiently manage laboratory information and workflows. The report, COVID-19 Impact on Sysmex Corps Revenue and Operations (Medical Devices) presents a deep dive analysis into how Sysmex Corp is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Deep dive analysis into how Sysmex Corp is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Key Highlights

- The global spread of COVID-19 has put much of Sysmexs business at risk, especially since the company has a significant presence in Asia Pacific (APAC), the US and Europe.
- Sysmex reported a 3.9% decrease in year-over-year (YoY) revenues during their fiscal second quarter ending on September 30th 2020, primarily due to decreased instrument and reagent sales both domestically and internationally.It expects that sales will continue to recover during the remainder of 2020, although APAC (excluding China) may continue to struggle reaching positive YoY growth.

Scope

The report provides a comprehensive analysis of the impact of COVID-19 on Sysmex Corp -
- It provides insights on Sysmex Corps exposure to the regions and businesses impacted by the COVID-19 outbreak.
- It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.

Reasons to Buy

- An overview of how Sysmex Corp will be affected by the COVID-19 pandemic.


COVID-19 impact analysis on Edwards Lifesciences Corp - Key Findings
Edwards Lifesciences Corp. Key Facts
Geographic spread analysis - COVID-19 vs Edwards Lifesciences Corp. sales
The impact of COVID-19 on regional GDP per capita levels
Edwards Lifesciences Corp. exposure: revenues by region and market vs regional impact levels
Edwards Lifesciences : revenue impact by region and market for 2020
Operational reactions from Edward Lifesciences? Indications from recruitment trends
Operational reactions from Edwards’ Indications from US pricing trends
Contact us


Global Peptide Therapeutics Market (2021 Edition) – Analysis By Drug Type (Generic, Innovative), Manufacturing Type (In-House, Outsourced), Application,, By Region, By Country: Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)

Executive The Global Peptide Therapeutics Market is valued at USD 32.1 Billion in the year 2020. The growth of Peptide Therapeutics is directly associated with drug development. New drug discovery

USD 2400 View Report

COVID-19 Impact on Anheuser-Busch InBev, Update 2021

COVID-19 Impact on Anheuser-Busch InBev, Update 2021 COVID-19 Impact on Anheuser-Busch InBev, Update 2021 reports key findings as of 23rd March, 2021 based on market analysis and brand diversification by industry

USD 1450 View Report

Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 Update

Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 UpdateThis 62-page PowerPoint based report gives an important update to the previous year with an expert analysis on how COVID-19 is

USD 1495 View Report

Global Peptide Therapeutics Market (2021 Edition) – Analysis By Drug Type (Generic, Innovative), Manufacturing Type (In-House, Outsourced), Application,, By Region, By Country: Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)

Executive The Global Peptide Therapeutics Market is valued at USD 32.1 Billion in the year 2020. The growth of Peptide Therapeutics is directly associated with drug development. New drug discovery

USD 2400 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available